We are live on ! Find out more
AVM

Arch Venture Management Portfolio holdings

AUM $677M
1-Year Est. Return 322.07%
This Fund
S&P 500
This Quarter Est. Return
-3.71%
1 Year Est. Return
+322.07%
3 Year Est. Return
+208.96%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$154M
AUM Growth
-$7.99M
Cap. Flow
+$9.28M
Cap. Flow %
6.03%
Top 10 Hldgs %
100%
Holding
7
New
1
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
GOSS icon
Gossamer Bio
GOSS
+$9.28M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EQRX
1
DELISTED
EQRx, Inc. Common Stock
EQRX
$80.7M 52.39%
36,335,375
– –
VERV
2
DELISTED
Verve Therapeutics
VERV
$26.6M 17.3%
2,008,809
– –
ERAS icon
3
Erasca
ERAS
$6.66B
$21.8M 14.15%
11,055,554
– –
DNLI icon
4
Denali Therapeutics
DNLI
$3.7B
$14.3M 9.3%
693,749
– –
GOSS icon
5
Gossamer Bio
GOSS
$68.9M
$6.71M 4.36%
+8,055,916
New +$9.28M
UBX
6
DELISTED
Unity Biotechnology
UBX
$2.41M 1.57%
1,004,817
– –
OMIC
7
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$1.45M 0.94%
126,631
– –

Similar funds

NI
Noked Israel Ramat Hasharon, Israel $677M AUM 69.37% 1-Year Est. Return
MMPW
Mitchell McLeod Pugh & Williams Mobile, Alabama $678M AUM 23.02% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
NCM
Noesis Capital Mangement Boca Raton, Florida $676M AUM 34.17% 1-Year Est. Return
TWM
Topsail Wealth Management Charlotte, North Carolina $678M AUM 13.87% 1-Year Est. Return
DLIC
Daido Life Insurance Company Osaka, Japan $678M AUM 16.09% 1-Year Est. Return
REAM
Ripple Effect Asset Management New York $679M AUM 81.6% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return

Arch Venture Management's Q3 2023 Portfolio in Review

As of Q3 2023, Arch Venture Management held 7 positions worth $154M, down 4.9% from $162M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Arch Venture Management deployed $9.28M of net new capital in Q3 2023, opening 1 new position. Its largest new stake was Gossamer Bio: 8,055,916 shares worth $6.71M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Arch Venture Management's largest Q3 2023 buy was Gossamer Bio: 8,055,916 shares worth $6.71M.
  • Arch Venture Management's ten largest holdings make up 100% of its $154M portfolio in Q3 2023.
  • Arch Venture Management opened 1 new position and closed 0 in Q3 2023.
  • Arch Venture Management's portfolio value fell 4.9% quarter-over-quarter to $154M.

Based on Arch Venture Management's 13F filing for Q3 2023, filed 14 Nov 2023.